Fujian Haixi Pharmaceuticals, Inc.

Follow

Organization

Fuzhou, Fujian, CN

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Heteroaryl compounds as kinase inhibitor
- Patent number 11,767,296
- Issue date Sep 26, 2023
- FUJIAN HAIXI PHARMACEUTICALS CO., LTD.
- Yan Feng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compound and use thereof in synthesis of brivaracetam intermediate...
- Patent number 11,247,977
- Issue date Feb 15, 2022
- FUJIAN HAIXI PHARMACEUTICALS CO., LTD.
- Yan Feng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compound for increasing kinase active and application thereof
- Patent number 9,409,900
- Issue date Aug 9, 2016
- FUJIAN HAIXI PHARMACEUTICALS, INC.
- Xinshan Kang
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
HETEROARYL COMPOUNDS AS KINASE INHIBITOR
- Publication number 20220380312
- Publication date Dec 1, 2022
- FUJIAN HAIXI PHARMACEUTICALS CO., LTD.
- Yan FENG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUND AND USE THEREOF IN SYNTHESIS OF BRIVARACETAM INTERMEDIATE...
- Publication number 20210261515
- Publication date Aug 26, 2021
- FUJIAN HAIXI PHARMACEUTICALS CO., LTD.
- Yan FENG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CARBOXYLIC ACID COMPOUNDS IN TREATMENT OF DIABETES MELLITUS
- Publication number 20160200734
- Publication date Jul 14, 2016
- FUJIAN HAIXI PHARMACEUTICALS CO., LTD.
- Xinshan KANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUND FOR INCREASING KINASE ACTIVE AND APPLICATION THEREOF
- Publication number 20130225587
- Publication date Aug 29, 2013
- Zhejiang Beta Pharma Incorporation
- Xinshan Kang
- C07 - ORGANIC CHEMISTRY